These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7339515)

  • 1. [Platelet aggregation in patients with chronic renal insufficiency not under dialytic treatment].
    Camici M; Evangelisti L; Balestri PL
    Minerva Nefrol; 1981; 28(4):467-70. PubMed ID: 7339515
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet aggregation before and after hemodialysis in chronic renal insufficiency.
    Kageyama T; Oyabu H; Tsumoto S; Kimoto S; Toda H
    Bull Osaka Med Sch; 1983 Oct; 29(2):62-8. PubMed ID: 6680327
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes of the platelet aggregation in patients with chronic renal insufficiency under extracorporeal dialysis].
    Grgicević D; Antos M; Pistotnik M; Prejac M; Flego I
    Lijec Vjesn; 1975 Oct; 97(9):509-12. PubMed ID: 1223580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathophysiology of platelet anomalies and its analysis. (3). Platelet aggregation, with special reference to clinical evaluation of the platelet aggregation in patients with diabetes mellitus and those under chronic hemodialysis].
    Matsuo T
    Rinsho Byori; 1983 Nov; 31(11):1168-75. PubMed ID: 6672292
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of platelet hemostasis in patients with chronic renal failure].
    Krawczyk W; Dmoszyńska A; Sokołowska B
    Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differences in mechanisms of alterations in thrombocyte and erythrocyte aggregation in renal failure].
    Potapova IV; Potapov VV
    Biull Eksp Biol Med; 1980 Mar; 89(3):263-5. PubMed ID: 7388129
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombocyte and erythrocyte aggregation and serotonin activity in patients with chronic renal failure].
    Alekseev GI; Potapov VV; Potapova IV
    Ter Arkh; 1979; 51(6):55-8. PubMed ID: 473052
    [No Abstract]   [Full Text] [Related]  

  • 8. [Criteria of the evaluation of the aggregative capacity of thrombocytes in patients with chronic renal failure during hemodialysis].
    Rud'ko IA; Kubatiev AA; Kulakov GP
    Urol Nefrol (Mosk); 1988; (3):48-53. PubMed ID: 3218007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal failure and cardiovascular risk. Increased borderline serum creatinine--a warning sign?].
    Mann J
    MMW Fortschr Med; 2001 Nov; 143(48):30-4. PubMed ID: 11770372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in platelet aggregation in patients on a chronic intermittent dialysis program].
    Malý J; Erben J; Pecka M; Jebavý L; Bláha M; Siroký O
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):295-306. PubMed ID: 6985168
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parameters of renal insufficiency in aged patients with normal values of creatinine in the blood].
    Duraković Z
    Acta Med Iugosl; 1985; 39(2):125-34. PubMed ID: 4024988
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure.
    Park SH; Kim W; Park CS; Kang WY; Hwang SH; Kim W
    Am J Cardiol; 2009 Nov; 104(9):1292-5. PubMed ID: 19840579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The optimization of the treatment and timing of the intervention by a nephrologist in pre-dialytic chronic renal insufficiency].
    Sirignano C; D'Urso P; Di Iorio BR;
    G Ital Nefrol; 2003; 20(2):133-8. PubMed ID: 12746798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration by Jaffé reaction of serum substances in chronic renal insufficiency].
    Desprez T; Arens G; Degremont G; Raviart B; Dequiedt P; Dracon M; Lelievre G; Tacquet A
    Lille Med; 1980 Apr; 25(4):126-31. PubMed ID: 7392763
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between creatinine clearance and plasma homocysteine levels in predialytic chronic renal failure patients.
    Widiana IG; Suwitra K
    Acta Med Indones; 2004; 36(1):15-8. PubMed ID: 15931697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle molecules evaluation in chronic renal failure during conservative treatment.
    Severini G; Carta S; Taccone-Gallucci M; Mazzarella V; Iacona A; Meloni C; Casciani CU
    Ann Ist Super Sanita; 1983; 19(2-3):417-9. PubMed ID: 6681233
    [No Abstract]   [Full Text] [Related]  

  • 17. Propyl gallate-induced platelet aggregation in patients with end-stage renal disease: the influence of the haemodialysis procedure.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Tsiandoulas A; Barboutis K; Stefanidis I
    Nephrology (Carlton); 2006 Feb; 11(1):3-8. PubMed ID: 16509924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine in renal failure.
    Hultberg B; Andersson A; Sterner G
    Clin Nephrol; 1993 Oct; 40(4):230-5. PubMed ID: 8261681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
    Hottelart C; el Esper N; Achard JM; Pruna A; Fournier A
    Nephrologie; 1999; 20(1):41-4. PubMed ID: 10081035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
    Carreras LO; Chamone DA; Vermylen J
    Sangre (Barc); 1981; 26(4):427-32. PubMed ID: 7027492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.